Literature DB >> 6792262

Impaired prolactin secretion in obese patients.

F Cavagnini, C Maraschini, M Pinto, A Dubini, E E Polli.   

Abstract

To investigate a possible hypothalamic alteration in obesity, we have studied the pattern of PRL secretion in response to insulin hypoglycemia, arginine infusion and TRH injection in 12 grossly obese patients and in 12 normal-weight controls. In the obese patients, PRL secretion was significantly lower than in normal subjects in response to insulin hypoglycemia and arginine infusion, while it was not significantly different from that in controls in response to TRH. The mean +/- SE values of the areas subtended by the PRL curves in the 3 above tests were 54.7 +/- 155.81 vs 3677.3 +/- 520.30 ng/2h, p less than 0,01, 210.3 +/- 148.93 vs 1034.8 +/- 203.15 ng/2h, p less than 0.05 and 1476.8 +/- 275.13 vs 2148.6 +/- 682.06 ng/2h, NS, respectively, in the obese and in controls. These results are compatible with the concept of impaired hypothalamic control of PRL secretion in obesity, although it is still unclear what role this may play in the pathogenesis of this disorder.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6792262     DOI: 10.1007/BF03350443

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  35 in total

1.  The effects of opiate agonist and antagonist on serum prolactin in primates: possible role for endorphins in prolactin regulation.

Authors:  M S Gold; D E Redmond; R K Donabedian
Journal:  Endocrinology       Date:  1979-07       Impact factor: 4.736

2.  Leu-enkephalin-stimulated growth hormone and prolactin release in the rat: comparison with the effect of morphine.

Authors:  D Cocchi; A Santagostino; I Gil-Ad; S Ferri; E E Müller
Journal:  Life Sci       Date:  1977-06-15       Impact factor: 5.037

3.  [Obesity and the somatotropic hormone. I. Somatotropin secretion in obesity].

Authors:  G Giordano; E Foppiani; F Minuto; M Marugo
Journal:  Folia Endocrinol       Date:  1974-08

4.  [Behavior of somatotropic hormone and plasmatic NEFA during function tests in essential obesity].

Authors:  G Iacono; A Ghionni; D Palomba; N Del Giudice; M Colucci
Journal:  Acta Diabetol Lat       Date:  1971 Jan-Feb

5.  The effect of weight loss on the growth hormone response to arginine infusion in obesity.

Authors:  A Z el-Khodary; M F Ball; B Stein; J J Canary
Journal:  J Clin Endocrinol Metab       Date:  1971-01       Impact factor: 5.958

6.  Effects of insulin-induced hypoglycemia on the plasma cortisol and growth-hormone levels in obese and diabetic persons.

Authors:  M Góth; J Gönczi
Journal:  Endokrinologie       Date:  1972-06

7.  Endocrine disturbances in childhood obesity: growth-hormone and cortisol response to insulin induced hypoglycemia.

Authors:  J Girard; M Stahl; P W Nars; J B Baumann
Journal:  Klin Wochenschr       Date:  1972-07-15

8.  Effect of weight reduction, triiodothyronine, and diethylstilbestrol on growth hormone in obesity.

Authors:  H J Londono; T F Gallagher; G A Bray
Journal:  Metabolism       Date:  1969-12       Impact factor: 8.694

9.  Impaired hypothalamic control of prolactin secretion in massive obesity.

Authors:  P G Kopelman; N White; T R Pilkington; S L Jeffcoate
Journal:  Lancet       Date:  1979-04-07       Impact factor: 79.321

10.  beta-Endorphin is associated with overeating in genetically obese mice (ob/ob) and rats (fa/fa).

Authors:  D L Margules; B Moisset; M J Lewis; H Shibuya; C B Pert
Journal:  Science       Date:  1978-12-01       Impact factor: 47.728

View more
  5 in total

1.  Thyroid-stimulating hormone and prolactin responses to thyrotropin-releasing hormone in juvenile obesity before and after hypocaloric diet.

Authors:  G Guzzaloni; G Grugni; D Moro; G Calò; E Tonelli; A Ardizzi; F Morabito
Journal:  J Endocrinol Invest       Date:  1995-09       Impact factor: 4.256

2.  Neuroendocrine alterations in obese patients with sleep apnea syndrome.

Authors:  Fabio Lanfranco; Giovanna Motta; Marco Alessandro Minetto; Matteo Baldi; Marcella Balbo; Ezio Ghigo; Emanuela Arvat; Mauro Maccario
Journal:  Int J Endocrinol       Date:  2010-02-23       Impact factor: 3.257

3.  Effect of fenfluramine on prolactin and thyroid-stimulating-hormone response to thyrotropin-releasing-hormone in obese and normal women.

Authors:  G Argenio; G Bernini; M S Vivaldi; C Del Corso; F Monzani; L Baschieri; G Bertolozzi; R Santoni; F Franchi; M Luisi
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  The role of overweight and glucose tolerance in the impaired pituitary-gonadal axis of obese males.

Authors:  G Valenti; L Denti; A Banchini
Journal:  Acta Diabetol Lat       Date:  1986 Jul-Sep

Review 5.  The effects of hyperprolactinemia on bone and fat.

Authors:  Amal Shibli-Rahhal; Janet Schlechte
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.